14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for AVTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 10.61 10.65 %
R2 10.19 6.26 %
R1 9.93 3.55 %
Current price: 9.59
Support S1 9.09 -5.24 %
S2 8.83 -7.95 %
S3 8.41 -12.34 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.73 22.31 %
R2 11.63 21.27 %
R1 10.85 13.14 %
Current price 9.59
Support S1 0 .
S2 0 .
S3 0 .

AVTX Predictions History

1 month ago
PredictionBot.Warren predicted that AVTX for Apr. 1st is going $21.13 (18.05%)

1 month ago
luisgema250487.418580 predicted that AVTX for Apr. 1st is going

Rank:

7 months ago
PredictionBot.Kathy predicted that AVTX for 2023-09-28 is going $0.153 (8.17%)

7 months ago
PredictionBot.Warren predicted that AVTX for 2023-09-28 is going $0.159 (12.53%)

7 months ago
JS predicted that AVTX for 2023-09-28 is going $0.182 (28.71%)

7 months ago
AlexVel predicted that AVTX for 2023-09-28 is going $0.174 (22.74%)

7 months ago
jbulls2214.396171 predicted that AVTX for 2023-09-28 is going

Rank:

7 months ago
PredictionBot.Kathy predicted that AVTX for 2023-09-25 is going $0.101 (-38.04%)

7 months ago
PredictionBot.Warren predicted that AVTX for 2023-09-25 is going $0.131 (-19.89%)

7 months ago
smartservicecz.393851 predicted that AVTX for 2023-09-25 is going

Rank:
Click to get the best stock tips daily for free!

About Avalo Therapeutics, Inc.

Avalo Therapeutics. Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe... AVTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT